Multiple Sclerosis Drug Effectively Stops Mesothelioma Cells
Research from the University of Hawaii Cancer Center shows an immune suppression drug already used to treat multiple sclerosis could become an effective tool against malignant mesothelioma. The drug, fingolimod (FTY720), showed an ability to shrink mesothelioma tumors cells in the laboratory and in animal models without causing substantial side effects. Fingolimod, which is derived from the fungus isaria sinclairii, also is being studied for potential use with cervical, breast, lung and prostate cancers. This was the first study of its effectiveness with mesothelioma. The Journal of Translational Medicine published the res...
Source: Asbestos and Mesothelioma News - May 11, 2017 Category: Environmental Health Authors: Matt Mauney Tags: anti-cancer effect on mesothelioma cells Dr. Haining Yang fingolimod mesothelioma FTY720 immune suppression drugs isaria sinclairii Journal of Translational Medicine mesothelioma life expectancy multiple sclerosis drugs Repurposing drugs Source Type: news

New VA Health Care Bill Can Help Mesothelioma Patients
A recent extension and reform of the Veterans Choice Program could allow for better access to care for veterans diagnosed with rare cancers such as mesothelioma. President Donald Trump signed the Veterans Choice Program Extension and Improvement Act (S.544) into law on April 18. The bill amends the Veterans Access, Choice, and Accountability Act of 2014, eliminating the Aug. 7, 2017, expiration date and allowing the program to operate until the remaining $950 million in the Veterans Choice Fund is expended. Under the new law, military veterans can continue receiving health care in the private sector when care isn’...
Source: Asbestos and Mesothelioma News - May 10, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Aaron Munz David Shuklin Donald Trump mesothelioma life expectancy military veterans asbestos exposure pending VA claims President Barack Obama private health care for veterans Trump executive orders VA accountability and whistleblower p Source Type: news

FDA Cracks Down on Fake Mesothelioma Treatments
Stories abound of a “cancer-curing” tea from the forests of Canada. Herbal blends claim to “attack cancer at the DNA level.” For many years, mesothelioma patients have turned to alternative medicines like these as treatment options for the rare asbestos-related cancer. Sometimes these options are a last resort, after traditional treatments fail. They may be used in conjunction with standard treatment (complementary medicine) or on their own as the main approach. But the U.S. Food and Drug Administration (FDA) recently issued warning letters to companies that manufacture or market products claimin...
Source: Asbestos and Mesothelioma News - May 2, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Alternative medicine Asparagus Extract BioStar Technology International Budwig Protocol cancer supplements cannabis oil cancer CellAssure Centers for Disease Control and Prevention Chelated Boron Circulatory Detox & Support Syrup compl Source Type: news

New Mesothelioma Clinical Trial for Pleural, Peritoneal Patients
Pleural and peritoneal mesothelioma patients are eligible for a new clinical trial that combines the latest antibody-drug conjugate with standard-of-care chemotherapy at the Ochsner Medical Center in New Orleans. The drug, anetumab ravtansine (BAY 94-9343), is the highly touted conjugate that mixes immunotherapy with cytotoxic therapy and targets mesothelin, the tumor surface protein found in 85-90 percent of mesothelioma cancer patients. The Ochsner trial, which is currently recruiting participants, is the first time researchers will administer anetumab ravtansine in a first-line setting for mesothelioma. “It’...
Source: Asbestos and Mesothelioma News - April 28, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: anetumab ravtansine mesothelioma chemotherapy mesothelioma clinical trial new mesothelioma treatment ochsner clinical trial Source Type: news

Moffitt Opens Mesothelioma Study for Rare Cancer Subtypes
The Moffitt Cancer Center in Tampa has opened a mesothelioma clinical trial involving an anti-cancer enzyme drug showing unprecedented success with the most difficult disease subtypes. Patients with sarcomatoid and biphasic histology — the most treatment-resistant subtypes of mesothelioma — can now enroll in a phase 2/3 clinical trial involving the effectiveness of ADI-PEG 20 (pegylated arginine deiminase) in combination with standard chemotherapy. Thoracic surgeon Dr. Jacques Fontaine, director of the Mesothelioma Research and Treatment Center at Moffitt, told Asbestos.com that he and fellow investigators are ...
Source: Asbestos and Mesothelioma News - April 25, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: doctor jacques fontaine improving mesothelioma prognosis mesothelioma chemotherapy with cisplatin mesothelioma clinical trial mesothelioma treatments moffitt cancer center Source Type: news

Select Mesothelioma Patients Still Benefit from EPP Surgery
The controversial extrapleural pneumonectomy (EPP) surgery should remain a viable option for select patients with malignant mesothelioma, despite a growing reluctance today among thoracic surgeons to recommend the procedure. When combined with intensity modulated radiation therapy (IMRT), the EPP still can benefit some patients and improve survival times significantly, according to a recent study at the Baylor Scott & White Medical Center in Temple, Texas. The retrospective look at 18 patients who underwent the EPP/IMRT combination found an average, overall survival rate of 38.2 months and a median relapse-free surviva...
Source: Asbestos and Mesothelioma News - April 17, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: extrapleural pneumonectomy intensity modulated radiation therapy mesothelioma life expectancy mesothelioma surgery mesothelioma survival rates Source Type: news

Asbestos Contaminates Canadian University Labs
Fear and frustration best describes emotions felt by University of Toronto faculty and students after they say administration delayed notification that asbestos contaminated some of the university’s science labs. “The emotional experience is really devastating,” said physiology and medicine professor Adria Giacca in an interview with CBC News. Another professor, who didn’t want to be identified, told the Globe and Mail: “I’ve lost confidence, and my lab people have lost confidence…[It] perpetuates fear whenever you see dust, you now worry. Am I going to get cancer 20 years from no...
Source: Asbestos and Mesothelioma News - April 12, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos ban in canada asbestos exposure in canada asbestos exposure in schools asbestos in canada Source Type: news

Shorter Mesothelioma Survival Linked to High Platelet Count
A disorder that forces the body to overproduce platelets is now linked to worsening the prognosis of peritoneal mesothelioma patients, according to researchers at the University of Maryland School of Medicine. Previous clinical trials associated a high platelet count, also known as thrombocytosis, with poor outcomes for various malignancies. However, the recent study at The Greenebaum Comprehensive Cancer Center in Baltimore is the first to evaluate the clinical significance of thrombocytosis with mesothelioma cancer. The study, published March 21 in the Annals of Surgical Oncology, analyzed overall survival for peritoneal...
Source: Asbestos and Mesothelioma News - April 3, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: chemotherapy for mesothelioma heated intraperitoneal chemotherapy hyperthermic intraperitoneal chemotherapy mesothelioma survival peritoneal mesothelioma survival platelet count for mesothelioma thrombocytosis for mesothelioma Source Type: news

Keytruda Proves Effectiveness with Mesothelioma
This study provides evidence that some patients [with mesothelioma] can have long-term disease control with this drug, which we haven’t seen before,” Alley said in a press release. “This drug appears to be well tolerated.” Real Need for Second-Line Therapy Standard first-line therapy for mesothelioma includes a combination of chemotherapy, radiation and surgery, but it remains relatively ineffective as a long-term solution. Alley believes pembrolizumab, classified as a checkpoint inhibitor drug, can provide a needed advancement in treatment. Checkpoint inhibitors allow the immune system to fight off...
Source: Asbestos and Mesothelioma News - March 31, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Abramson Cancer Center checkpoint inhibitors Dr. Evan Alley keytruda keytruda clinical trials keytruda for mesothelioma Merck & Co. PD-L1 proteins pembrolizumab Pembrolizumab mesothelioma Penn Medicine Penn Presbyterian Medical Cente Source Type: news

Nutritional Index Helps Predict Mesothelioma Prognosis
A recent study further expands on the important role nutrition plays in how well mesothelioma patients will respond to treatments. Researchers in Japan evaluated the Controlling Nutritional Status (CONUT) score — an index developed as a screening tool for early detection of poor nutritional status — as a predictive marker for mesothelioma prognosis. CONUT has been used to predict the prognosis of other cancers, but never for malignant pleural mesothelioma (MPM), a rare and aggressive cancer caused by exposure to asbestos. “The CONUT score was an independent predictor of a poor prognosis in the patients...
Source: Asbestos and Mesothelioma News - March 29, 2017 Category: Environmental Health Authors: Matt Mauney Tags: bap1 gene mutation Controlling Nutritional Status score CONUT score malignant pleural mesothelioma mesothelioma malnutrition mesothelioma nutrition Mesothelioma prognosis mesothelioma stages nutrition mesothelioma survival Osaka City Uni Source Type: news

Mesothelioma Researcher Questions Benefits of EPP Surgery
Former thoracic surgeon Dr. Tom Treasure at University College London was never a believer in the aggressive extrapleural pneumonectomy (EPP) surgery still performed today for patients with malignant pleural mesothelioma. As a researcher now, he dismisses the potential benefit with even more conviction. “Doing the EPP can’t be justified anymore,” Treasure told Asbestos.com. “One more [of these surgeries] is one too many. I feel more confident about that now than ever before. We really have to spare people from the treatments that don’t help.” In recent years, the mesothelioma community h...
Source: Asbestos and Mesothelioma News - March 27, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: doctor david sugarbaker Doctor Tom Treasure EPP surgery for mesothelioma lung institute at baylor mesothelioma surgery mesothelioma treatment pleurectomy decortication Source Type: news

Veterans with Mesothelioma Benefit from Telephone Triage
U.S. military veterans with malignant pleural mesothelioma can rely on the VA Boston Healthcare System’s national phone triage for improved access to specialized surgical advice and better treatment recommendations, according to a retrospective study. Thoracic surgeons Drs. Abraham Lebenthal and Jeff Siegert helped establish the open access telephone triage in 2011, shortening the average time between a veteran’s initial phone screen and face-to-face surgical consultation to 14 days. Many veterans facing a potential diagnosis of mesothelioma must navigate the historically mismanaged federal agency to get the tr...
Source: Asbestos and Mesothelioma News - March 20, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Boston VA Brigham and Women’s Hospital Dr. Abraham Lebenthal Dr. Jeff Siegert malignant pleural mesothelioma military veterans mesothelioma Telephone triage VA benefits Source Type: news

Trump Will Likely Support Asbestos FACT Act
A House Judiciary Committee approved the Furthering Claims Transparency Act of 2017, one of numerous iterations of the legislation since 2004, which asbestos foes claim will hurt those seeking much-deserved compensation. Repeatedly stalled in the legislature in previous years with a promised veto from President Barack Obama, supporters are hopeful President Donald Trump will support the bill as part of a reform package. Republican sponsor U.S. Rep. Blake Farenthold of Texas introduced the bill in February. Opponents Fear Asbestos Victims’ Privacy Is at Stake Linda Reinstein, president of the Asbestos Disease Awarenes...
Source: Asbestos and Mesothelioma News - March 7, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: Asbestos Disease Awareness Organization asbestos trust claims asbestos trusts FACT Act filing an asbestos trust claim Furthering Claims Transparency Act of 2017 Linda Reinstein trump asbestos U.S. Rep. Blake Farenthold Source Type: news

Hospice Program Eases Breathing for Mesothelioma Patients
Dr. Michael Shapiro has developed a program that should make breathing easier for a patient with malignant pleural mesothelioma. He equates his breathing program to teaching an elite athlete how to better utilize his lung capacity by using similar concepts that assist people struggling with serious respiratory issues in hospice care. “We’re not reinventing the wheel, by any stretch of the imagination,” Shapiro told Asbestos.com. “But there are ways to teach people, at all levels, to breath more efficiently. Our goal is to help provide a better quality of life for a patient.” Shapiro is the chi...
Source: Asbestos and Mesothelioma News - March 3, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: breathing exercises for mesothelioma dr. michael shapiro hospice care for mesothelioma mesothelioma treatment Source Type: news

Firefighters with Mesothelioma Protected by New Ohio Law
A new piece of legislation extends workers’ compensation rights for Ohio firefighters to include occupational cancers such as mesothelioma. Ohio Gov. John Kasich signed the Michael Louis Palumbo Jr. Act into law Jan. 4. The bill essentially classifies cancer as an occupational disease for firefighters, allowing firefighters who have cancer to file claims with the Ohio Bureau of Workers’ Compensation. More than 30 states already have similar laws. Doug Stern of the Ohio Association of Professional Firefighters (OAPFF) said the legislation is based on scientific research that links asbestos-related cancers, suc...
Source: Asbestos and Mesothelioma News - January 30, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: firefighters asbestos exposure firefighters with mesothelioma governor john kasich occupational mesothelioma cancer ohio law protects firefighters Source Type: news

$80M Asbestos Settlement Reached in Kansas City
An $80 million asbestos settlement involving two former Jackson County courthouse employees led to Missouri’s largest medical monitoring fund established in an asbestos case. The class-action asbestos lawsuit settled more than 30 years after a renovation exposed thousands of government workers to deadly asbestos fibers. Jackson County and Kansas City-based U.S. Engineering, the firm responsible for the asbestos removal, agreed to settle the case in October 2016, just a week prior to the opening trial date. An estimated 7,500 people — former courthouse employees, jurors, attorneys and jail inmates — could...
Source: Asbestos and Mesothelioma News - January 25, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos in kansas city courthouse asbestos lawsuit asbestos litigation in missouri asbestos settlement kansas city asbestos lawsuit kansas city asbestos settlement mesothelioma lawsuit mesothelioma lawyer in missouri Source Type: news

Study Finds Unique Mesothelioma Incidence Rates in China
A study analyzing mesothelioma incidence rates in Eastern China produced unusual findings, contrasting significantly from statistics of the asbestos-related cancer in the U.S. Reported incidence rates in China are significantly lower than the U.S. Only 15 percent of cases examined in the study were linked to asbestos exposure, the overwhelming cause of mesothelioma in most countries around the world. China’s results are contradictory for a country which remains one of the world’s largest producers and users of the carcinogenic mineral. Other contrasting findings from the study: Peritoneal mesothelioma cas...
Source: Asbestos and Mesothelioma News - January 23, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos exposure in china asbestos use in china mesothelioma in china nonasbestos mesothelioma peritoneal mesothelioma in china Source Type: news

EPA: ‘ Last Call ’ for Asbestos Cleanup in Libby, Montana
The U.S. Environmental Protection Agency (EPA) has made a “last call” at the Libby Asbestos Superfund site, giving residential and commercial property owners one final chance to benefit from its asbestos cleanup efforts. Property owners in Libby and nearby Troy, Montana, will have until March 31 to sign up, bringing closure to the largest, longest-running asbestos cleanup project in American history. “This last call really signals the end of the project, which has been a bit of a dark cloud hanging over our area for some time,” Nick Raines, manager of the Lincoln County Asbestos Resources Program, t...
Source: Asbestos and Mesothelioma News - January 18, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos cleanup in libby montana asbestos exposure in montana asbestos in libby asbestos regulations asbestos removal in libby montana asbestos superfund site in libby asbestos superfund sites epa asbestos cleanup Source Type: news

Mesothelioma Vaccine Aims to Stop Cancer Before It Begins
Dr. Pietro Bertino can envision a time when mesothelioma cancer no longer exists. He can see it through the work he does every day. Bertino is an assistant researcher in the Cell and Molecular Biology Department at the John A. Burns School of Medicine at the University of Hawaii. The U.S. Department of Defense awarded Bertino a three-year, $550,000 research grant to advance the development of a multiantigen mesothelioma vaccine aimed at prevention and therapeutics. His early work shows significant promise. “We are making progress. You can already see it,” Bertino told Asbestos.com. “It’s going to ...
Source: Asbestos and Mesothelioma News - January 17, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: bap1 gene mutation john a burns school of medicine mesothelioma grants mesothelioma research grant mesothelioma vaccine pietro bertino university of hawaii cancer center Source Type: news

Heating Tumors May Improve Mesothelioma Treatments
A recent study shows heating malignant tumors could improve treatments for mesothelioma and other cancers. Researchers in France successfully softened malignant tumors by heating them, a process known as nanohyperthermia, which altered the collagen fibers and reduced the rigidity and volume of the tumors, making them more susceptible to chemotherapy and other therapeutic treatments. Malignant tumors, such as those found in mesothelioma patients, demonstrate a mechanical resistance to standard treatments, hindering efforts to defeat cancers. Stiffening is a characteristic of cancer cells, and one that may help the cells p...
Source: Asbestos and Mesothelioma News - January 13, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: heating cancer tumors mesothelioma treatments new mesothelioma treatments treating cancer with carbon nanotubes treating peritoneal mesothelioma treating pleural mesothelioma Source Type: news

Mesothelioma Patients Benefit from Integrative Medicine Expert
Dr. Ka-Kit Hui is no expert on mesothelioma cancer, but he helps mesothelioma patients live longer and better lives every day. Committed to teaching the benefits of integrative medicine, Hui’s vision blends the best of traditional Chinese and conventional Western medicines, skillfully bridging the gap between the two. He launched the UCLA Center for East-West Medicine in 1993 — one of the first integrative medicine centers in the U.S. — leading it to national prominence. Clinically proven to improve health and healing, its programs often increase survival time. “Our hope is to do things that impro...
Source: Asbestos and Mesothelioma News - January 12, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: doctor ka-kit hui at ucla east west medicine integrative medicine for mesothelioma international symposium on malignant mesothelioma mesothelioma research Source Type: news

Early Detection of Mesothelioma Lies in HMGB1 Isoforms
An international research team is exploring how variants of an important blood protein could be the key to prevention and early detection of malignant mesothelioma. Dr. Haining Yang at the University of Hawaii Cancer Center is leading the research and recently presented potential strategies at the 6th International Symposium on Malignant Pleural Mesothelioma. Previously, Yang and her team showed how the High-Mobility Group Box 1 (HMGB1) protein sparks the proliferation and survival of cancerous mesothelioma cells. Yang and colleagues recently discovered that isoforms or “protein variants” of HMGB1 could be a ...
Source: Asbestos and Mesothelioma News - January 9, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: early detection of mesothelioma early diagnosis of mesothelioma early mesothelioma diagnosis hmgb1 isoforms malignant pleural mesothelioma mesothelioma research mesothelioma survival Source Type: news

Canada Will Ban Asbestos by 2018
After the latest push from unions and federal labor advocates, the Canadian government is moving to ban asbestos by 2018. Science Minister Kirsty Duncan announced the long-awaited news in late December. The ban will apply to the manufacture of any products containing asbestos, as well as imports made with the deadly mineral. It could be extended to products already manufactured. New Democrat Party Critic for Labour Sheri Benson introduced Bill C-321 in November to help speed the process. Despite a steep decline in global demand and Canada’s last asbestos mines closing in 2012, the Canadian government continued to dr...
Source: Asbestos and Mesothelioma News - January 4, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos ban asbestos ban in canada asbestos deaths in canada asbestos in canada justin trudeau asbestos ban mesothelioma in canada Source Type: news

Sugarbaker Touts New Clinical Study for Mesothelioma Patients
This study expands on what we already know about surgery and chemotherapy for mesothelioma, and combines them in a new way…with the goal of reducing recurrence rates and improving survival and quality of life,” Groth said in a press release from the Baylor Medical Center. “The heated chemotherapy fluid is effective at killing cancer and making the chemotherapy work better.” Baylor also has other ongoing mesothelioma clinical trials: A phase II study of anetumab ravtansine for patients with unresectable pleural mesothelioma and high expression of mesothelin, a vulnerable, tumor-surface protein link...
Source: Asbestos and Mesothelioma News - December 22, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: baylor college of medicine chemotherapy for mesothelioma dr. david sugarbaker mesothelioma chemotherapy drugs mesothelioma clinical trial mesothelioma treatment center at baylor Source Type: news

Mesothelioma Trial for Nintedanib Shows Positive Results
Researchers have reported more promising results from an international, multicenter phase II clinical trial of the drug nintedanib, moving it another step closer to standard-of-care treatment for pleural mesothelioma. Nintedanib is a small-molecule enzyme inhibitor being studied as a way to increase the effectiveness of chemotherapy on mesothelioma and certain types of lung cancer. Researchers presented the results earlier this month at the World Conference on Lung Cancer in Vienna, Austria. The randomized clinical trial treated mesothelioma patients with a placebo and chemotherapy (pemetrexed/cisplatin) or nintedanib and ...
Source: Asbestos and Mesothelioma News - December 22, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: chemotherapy clinical trial chemotherapy for mesothelioma extending mesothelioma survival mesothelioma treatment nintedanib Source Type: news

Study Shows Impact of Chemotherapy on Mesothelioma
A U.S.-based study confirms what oncology experts have suggested for years — chemotherapy treatment prolongs life expectancy for malignant mesothelioma patients. Wayne State University School of Medicine researchers linked data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database with Medicare claims data. The study took into account patient characteristics such as age, gender and amount of asbestos exposure. Not only did the findings show mesothelioma patients who have chemotherapy live longer, but it also proved multimodal therapy increases survival even more. The s...
Source: Asbestos and Mesothelioma News - December 19, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: chemotherapy clinical trial chemotherapy for mesothelioma doctor shirish gadgeel first line treatment for mesothelioma Human Investigation Committee at Wayne State mesothelioma diagnosis peritoneal mesothelioma wayne state university Source Type: news

Pearl Harbor: 75th Anniversary & Future Asbestos Dangers for Veterans
Seventy-five years later, Dec. 7, 1941, still lives in infamy. Wednesday marks the 75th anniversary of the attack on Pearl Harbor. The surprise Japanese military strike killed 2,403 Americans and wounded another 1,178, devastating the U.S. naval base and dragging the nation into World War II. But the death toll continued to rise decades after the attack because more than 10,000 veterans who served in Pearl Harbor were exposed to deadly asbestos released at the shipyards on the day of the attack. As we remember the lives lost in the attack and honor the survivors still with us today on Pearl Harbor Day, it is important to ...
Source: Asbestos and Mesothelioma News - December 7, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: 75 years after pearl harbor pearl harbor 75th anniversary pearl harbor attack pearl harbor attack anniversary veterans exposed to asbestos Source Type: news

Cryoablation Successfully Treats Recurrent Mesothelioma
Radiologists at the UCLA Medical Center are successfully killing tumor cells with extreme cold, also known as cryoablation, in patients with recurrent pleural mesothelioma. An outpatient procedure with few complications, cryoablation freezes the localized tumors with argon gas or liquid nitrogen, allowing patients to fight the almost-inevitable cancer recurrence after surgery. Dr. Fereidoun Abtin, a UCLA radiologist who performs the procedure, told Asbestos.com he is “convinced it works well for these patients.” “The results have been impressive, a lot better than what else is out there in the literature ...
Source: Asbestos and Mesothelioma News - December 6, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cryoablation for cancer cryoablation for mesothelioma cryosurgery for mesothelioma cryotherapy for mesothelioma freezing cancer tumors mesothelioma treatment Source Type: news

Extending Late-Stage Mesothelioma Survival with Light Energy
Thoracic surgeon Dr. Joseph Friedberg and his colleagues identified a subset of patients with pleural mesothelioma who achieved a median overall survival of 7.3 years — an impressive survival compared to the usual one-year prognosis. The findings, which were published recently in The Annals of Thoracic Surgery, stemmed from a retrospective study that detailed significant progress in the fight against this incurable, asbestos-related cancer. The study included 73 patients with epithelioid mesothelioma who were treated at the Penn Medicine Abramson Cancer Center, where Friedberg practiced before taking the role of dire...
Source: Asbestos and Mesothelioma News - December 1, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: doctor joseph friedberg late stage mesothelioma stage 3 mesothelioma stage 4 mesothelioma stage III mesothelioma stage IV mesothelioma treatment for late stage mesothelioma treatment for pleural mesothelioma Source Type: news

Study Uncovers Strange Growth of Mesothelioma Tumors
A new analysis on how asbestos-related tumors grow may lead to more effective research and treatments of malignant mesothelioma. Researchers at Australia’s Flinders University found malignant mesothelioma tumors demonstrate vasculogenic (vascular) mimicry — the process in which tumors make their own blood vessels. Tumors promote their own growth by growing blood vessels that reach into surrounding tissues instead of waiting for the outside of the tissue to grow blood vessels into the cancer cells. Oxygen and nutrients from blood vessels allow cancer cells to develop into secondary tumors. “[Vasculogen...
Source: Asbestos and Mesothelioma News - November 29, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cancer tumor growth chemotherapy for mesothelioma growth of mesothelioma tumors how do mesothelioma tumors grow mesothelioma clinical trials mesothelioma research mesothelioma treatment mesothelioma tumor growth Source Type: news

Environmental Asbestos Raises Mesothelioma Among Women
For decades, mesothelioma has predominately affected white men older than 60 years of age. This is largely because of the rare cancer’s connection to occupational asbestos exposure and its long latency period of 20 to 50 years. But as worldwide use of asbestos continues to decline and more industrialized countries continue to ban the toxic mineral, scientists are noticing a shift in age and gender when it comes to mesothelioma cases. University of New Caledonia epidemiologist Francine Baumann designed and performed a study analyzing environmental risk of mesothelioma in the U.S. and its effect on women and young p...
Source: Asbestos and Mesothelioma News - November 22, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos exposure in nevada asbestos exposure in women environmental asbestos environmental exposure to asbestos mesothelioma deaths from asbestos mesothelioma diagnosis mesothelioma in women Source Type: news

Record $18M Verdict in Mesothelioma-Talcum Powder Lawsuit
The recent record-setting $18 million verdict out of California rekindled the hotly debated link between talcum powder and mesothelioma cancer. A Los Angeles Superior Court jury awarded Philip Depoian the multimillion-dollar verdict against talc supplier Whittaker, Clark & Daniels. Depoian claimed the company’s asbestos-tainted talcum powder products used at the barbershop where his father worked exposed him to the deadly substance. He was diagnosed with mesothelioma, an aggressive cancer caused by asbestos exposure, in May 2015. Talcum powder is made from talc, one of the world’s softest minerals covete...
Source: Asbestos and Mesothelioma News - November 17, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos in talcum powder mesothelioma cancer from talcum powder mesothelioma from talcum powder talcum powder cancer talcum powder cancer verdict talcum powder lawsuit talcum powder mesothelioma lawsuit Source Type: news

Early Palliative Care Improves Mesothelioma Prognosis
Mesothelioma cancer patients can live longer and better lives if they begin palliative care sooner, according to a multidisciplinary panel of experts convened by the American Society of Clinical Oncology (ASCO). The panel recommended that palliative care options should be explored almost immediately after diagnosis of mesothelioma, a rare and aggressive cancer with no definitive cure. “The sooner the better,” Betty Ferrell, director of the Division of Nursing Research and Education at City of Hope Medical Center in Los Angeles, told Asbestos.com. “The evidence is strong.” Ferrell, who has 35 years ...
Source: Asbestos and Mesothelioma News - November 16, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: American Society of Clinical Oncology Betty Ferrell early palliative care mesothelioma treatment palliative care for cancer palliative care for mesothelioma treatment after early mesothelioma diagnosis Source Type: news

Tecentriq Raises Hope of New Mesothelioma Clinical Trial
The FDA recently approved immunotherapy drug Tecentriq (atezolizumab) for certain bladder and non-small cell lung cancers, raising hopes for a mesothelioma-specific clinical trial in 2017. Tecentriq, a product of Genentech Oncology, is following the path of Keytruda (pembrolizumab) and Opdivo (nivolumab) as drugs that target a specific protein blocking a body’s immune system from attacking cancer cells. The U.S. Food and Drug Administration sanctioned Keytruda and Opdivo earlier for non-small cell lung cancer, and those drugs are working their way through the clinical trial process for the treatment of mesothelioma. ...
Source: Asbestos and Mesothelioma News - November 10, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: atezolizumab bladder cancer drug for mesothelioma immunotherapy for mesothelioma keytruda for mesothelioma opdivo for mesothelioma tecentriq Source Type: news

New Zealand Asbestos Guide Aims to Reduce Deaths
New Zealand has a new guide for managing and removing asbestos in the workplace. The “Approved Code of Practice for the Management and Removal of Asbestos,” or ACOP, was designed to complement the Health and Safety at Work (Asbestos) Regulations 2016. Described as the first for the country, the new guide hopes to cut asbestos-related deaths in half by 2024. The new code took effect Nov. 3. Approximately 170 people in New Zealand die each year from asbestos-related diseases. Asbestos is the single greatest cause of death from work-related diseases, according to WorkSafe New Zealand, the government agency that&n...
Source: Asbestos and Mesothelioma News - November 9, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos dangers asbestos guide asbestos in new zealand mesothelioma in new zealand new asbestos guide new zealand asbestos guide occupational exposure to asbestos Source Type: news

Asbestos Mining Town in Canada Searches for New Identity
Asbestos wasn’t always an ugly word. Once hailed as a miracle fiber in manufacturing and construction, it is now scorned for its toxicity and link to mesothelioma and other deadly respiratory diseases. Perhaps no place knows that fall from grace better than the small town of Asbestos in southeast Quebec. Not only did the asbestos industry give the Canadian mining town its name, but it also shaped its identity, economy and legacy. The now defunct Jeffery Mine, which occupies nearly one-sixth of the town’s 12 square miles, was Canada’s largest asbestos mine and served as the town’s main employer whe...
Source: Asbestos and Mesothelioma News - November 7, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos in canada asbestos industry in canada asbestos town in quebec canada asbestos mines jeffrey mine in canada mesothelioma in canada Source Type: news

Red Wine Chemical Enhances Mesothelioma Chemotherapy
A new experimental treatment combining a chemical found in red wine and a popular chemotherapy drug showed a powerful synergistic effect in targeting pleural mesothelioma cells. Researchers at Soon Chun Hyang University Hospital Cheonan in South Korea combined the platinum-based chemotherapy drug cisplatin with resveratrol, a natural antioxidant found in wine and red grapes. The result successfully induced apoptosis, or the process of natural cell death, in malignant mesothelioma cells. Cisplatin has long been one of the most popular drugs to treat mesothelioma and a variety of other cancers. But like many chemotherapy d...
Source: Asbestos and Mesothelioma News - November 4, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: chemotherapy for mesothelioma cisplatin for mesothelioma mesothelioma treatment with red wine red wine for cancer resveratrol and cisplatin for cancer resveratrol in red wine Soon Chun Hyang University Hospital Cheonan Source Type: news

Using Keytruda for Mesothelioma May Become a Reality
The U.S. Food and Drug Administration recently upgraded its approval of pembrolizumab (Keytruda) for metastatic non-small cell lung cancer, inching it closer to becoming an accepted treatment option for pleural mesothelioma. Pembrolizumab, produced by pharmaceutical giant Merck & Co., also is marketed as Keytruda. The FDA’s announcement last week converted its previous “accelerated” approval in second-line treatment of lung cancer to regular first-line treatment for tumors that express the PD-L1 protein. This is the first FDA approval of a checkpoint inhibitor — a drug that unleashes an immune s...
Source: Asbestos and Mesothelioma News - November 2, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: clinical trials for mesothelioma first line treatment for mesothelioma immunotherapy for mesothelioma keytruda pembrolizumab pleural mesothelioma treatment Source Type: news

Definitive Radiation Therapy Extends Mesothelioma Survival
Patients with pleural mesothelioma are missing a chance to increase survival time because they are underutilizing definitive radiation, according to a recent study by the Icahn School of Medicine at Mount Sinai in New York City. A team of doctors found that overall survival at the two- and five-year marks almost doubled for the small number of patients who received radiation therapy, regardless of what other treatments were used. The research team recommended that doctors increase their use of definitive radiation therapy — radiotherapy as the primary treatment with a curative intent — for pleural mesothelioma....
Source: Asbestos and Mesothelioma News - October 26, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: definitive radiation for cancer definitive radiation therapy mesothelioma radiation mesothelioma treatment xrays for mesothelioma Source Type: news

Hoboken Train Crash Stirs Asbestos Concerns
High asbestos levels and extensive debris delayed the federal investigation of the Hoboken train crash in New Jersey for more than a week, officials said. Although officials reopened the majority of the rails at the Hoboken terminal this week, efforts to completely clean the century-old terminal will take even longer. The Sept. 29 crash killed 34-year-old Fabiola Bittar de Kroon and injured more than a hundred passengers and others waiting at the station. De Kroon was standing on the platform at the Hoboken train station when falling debris struck her, authorities said. The debris from the crash immediately became a con...
Source: Asbestos and Mesothelioma News - October 19, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos exposure in hoboken asbestos exposure in new jersey asbestos in hoboken hoboken train crash mesothelioma new jersey asbestos new jersey train crash occupational asbestos exposure in new jersey Source Type: news

Peritoneal Mesothelioma Grading System Improves Prognosis
The first two-tier grading system for peritoneal mesothelioma has produced a significant subset of patients with an incredible median overall survival of nearly 12 years. That pathology-based grading system should provide patients with a more accurate prognosis, potentially helping doctors design more personalized and effective therapies. “We can tell patients now what the future holds. That’s a big deal,” surgical oncologist Dr. Edward Levine, Comprehensive Cancer Center director at Wake Forest Baptist Health, told Asbestos.com. “We can now better prognosticate how our patients are likely to do.&rd...
Source: Asbestos and Mesothelioma News - October 10, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos related cancer Edward Levine mesothelioma mesothelioma grading system mesothelioma survival rates peritoneal mesothelioma wake forest baptist health cancer center Source Type: news

Sugarbaker: Mesothelioma Clinical Trial May Be ‘ Home Run ’
Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations, raising hopes around the country. The drug combines immunotherapy with cytotoxic therapy and targets mesothelin, a vulnerable tumor surface protein found in most mesothelioma patients. Earlier studies show ...
Source: Asbestos and Mesothelioma News - October 5, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: anetumab ravtansine BAY 94-9343 clinical trials for mesothelioma David Sugarbaker immunotherapy mesothelioma clinical trial mesothelioma treatment stage 4 mesothelioma stage IV mesothelioma Source Type: news

FDA Speeds Possible Second-Line Treatment for Mesothelioma
The U.S. Food and Drug Administration awarded Fast Track designation recently to the WT1 cancer vaccine, moving it closer to becoming the first approved second-line treatment for malignant pleural mesothelioma. The vaccine, also known as galinpepimut-S, is an immunotherapy agent that targets the WT1 protein, which is expressed in high levels in various cancers, such as mesothelioma, but it’s rarely seen in normal adult cells. The protein is especially resistant to standard chemotherapy agents. The National Cancer Institute in 2009 ranked WT1 as the top target of cancer immunotherapy research. Sellas Life Sciences Gro...
Source: Asbestos and Mesothelioma News - October 3, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: chemotherapy for mesothelioma immunotherapy for mesothelioma malignant pleural mesothelioma treatment second line mesothelioma treatment sellas life sciences group wt1 vaccine Source Type: news

Study: Onconase, Malaria Drug Extends Mesothelioma Survival
A new treatment combining two existing drugs — one derived from frog eggs and another given to combat malaria — may be the key to extending mesothelioma survival. Scientists at Tongji University in Shanghai, China, discovered that mixing Onconase, an enzyme present in early-stage leopard frog embryos, with antimalarial drug dihydroartemisinin (DHA) synergistically suppressed growth and angiogenesis of malignant mesothelioma, an aggressive cancer linked to asbestos exposure. Researchers investigated the antitumor effects of the drug combination in two ways — in vitro (in a test tube) and in vivo (in a li...
Source: Asbestos and Mesothelioma News - September 29, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: antitumor extending mesothelioma survival malaria drug malignant pleural mesothelioma mesothelioma clinical trial mesothelioma treatment onconase onconase clinical trial tongji university Source Type: news

New Lung Cancer Study May Improve Mesothelioma Therapy
New insight into the gene responsible for the most aggressive subtype of non-small cell lung cancer (NSCLC) could bring hope for mesothelioma patients. Researchers from UT Southwestern Medical Center identified a new way to target lung cancer through the Kirsten rat sarcoma viral oncogene homolog, also known as the KRAS gene. Tumors that carry a mutation in this gene account for about 30 percent of lung cancer cases, which are usually aggressive with a poor prognosis. Prior to the study, scientists had difficulty targeting the gene. The KRAS gene produces proteins called K-Ras, which influence cell division. Mutations i...
Source: Asbestos and Mesothelioma News - September 28, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos exposure asbestos lung cancer KRAS lung cancer KRAS mutation lung cancer study mesothelioma clinical trial mesothelioma research mesothelioma treatment Source Type: news

Orlando Won ’ t Face Fines for Exposing Firefighters to Asbestos
City of Orlando and Orlando Fire Department officials will not face any fines after firefighters were exposed to asbestos during a training exercise in February. Investigators met with Orange County Environmental Protection Division (EPD) officials and decided not to impose any penalties, which could have amounted to $25,000 for each violation. Instead, fire department officials will initiate an asbestos training program they expect to implement by November. “The EPD Air Quality Management Section has asked for this training as a Supplemental Environmental Project, in lieu of paying the assessed civil penalty,&rdquo...
Source: Asbestos and Mesothelioma News - September 26, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos exposure asbestos floor tiles asbestos in firefighting firefighters exposed to asbestos firefighters with mesothelioma orlando Deputy Fire Chief Gerald Lane orlando fire department orlando firefighters exposed to asbestos Source Type: news

Sen. Boxer: EPA Should Include Asbestos in Top Priorities
Selecting the 10 most dangerous chemicals in the U.S. is the first order of business under the recently strengthened arm of the Environmental Protection Agency. “EPA must consider all forms of asbestos in this initial list of chemicals it acts on,” U.S. Sen. Barbara Boxer, D-Calif., wrote in an Aug. 26 letter to EPA administrator Gina McCarthy. President Barack Obama signed the Frank R. Lautenberg Chemical Safety for the 21st Century Act into law in June, updating the antiquated Toxic Substances Control Act and granting the EPA more power to regulate toxic chemicals. Boxer, a ranking member of the Environment a...
Source: Asbestos and Mesothelioma News - September 23, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos ban asbestos cancer asbestos diseases epa asbestos regulations mesothelioma asbestos cancer mesothelioma cancer senator barbara boxer Toxic Substances Control Act Source Type: news

Europe Worried TTIP Agreement Will Relax Asbestos Ban
Critics of a proposed free trade agreement between the United States and the European Union believe the deal would undermine the asbestos ban that has existed in the EU since 2005. The Transatlantic Trade and Investment Partnership, also known as TTIP, has been under negotiations for three years. TTIP promises to bolster an already strong relationship between the U.S. and the 28-nation EU by boosting economic growth and adding to the more than 13 million American and EU jobs already supported by transatlantic trade and investment. But some European environmental and public health activists claim TTIP will threaten current ...
Source: Asbestos and Mesothelioma News - September 21, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos ban in canada asbestos ban in europe asbestos ban in the united states asbestos in europe ceta Committee for Asbestos Victims Comprehensive Economic and Trade Agreement David de Vreede Transatlantic Trade and Investment Partnershi Source Type: news

International Mesothelioma Conference Will Kick Off at UCLA
Thoracic surgeon and renowned mesothelioma specialist Dr. Robert Cameron will be hosting the 6th International Symposium on Malignant Pleural Mesothelioma on Saturday, Sept. 24, at the UCLA School of Medicine. Cameron, director of the UCLA Comprehensive Mesothelioma Program, is a global leader in the development of the lung-sparing pleurectomy/decortication surgery and a vocal advocate for military veterans who develop the asbestos-related disease. The conference will cover the latest in mesothelioma therapeutics, including novel immunotherapies, gene therapy, upcoming clinical trials and surgical advancements. The purpose...
Source: Asbestos and Mesothelioma News - September 19, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: 216 mesothelioma conference in california international mesothelioma conference International Symposium on Malignant Pleural Mesothelioma robert cameron UCLA Comprehensive Mesothelioma Program Source Type: news

Researchers Test Nintedanib in Mesothelioma Clinical Trial
Medical oncologist Dr. Rama Balaraman isn’t expecting any miracles from the pleural mesothelioma clinical trial involving nintedanib, the small-molecule enzyme inhibitor. She is expecting progress. Balaraman, at Florida Cancer Affiliates in Ocala, is participating in an international, multicenter trial that will expand the use of nintedanib within the U.S., giving patients another weapon in this fight against mesothelioma cancer. “It is potentially a new way of approaching [this disease], and it’s causing a lot of excitement,” Balaraman told Asbestos.com. “We are hopeful.” Nintedanib, al...
Source: Asbestos and Mesothelioma News - September 16, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: malignant pleural mesothelioma treatment mesothelioma cancer mesothelioma chemotherapy mesothelioma clinical trial nintedanib Ofev rama balaraman Source Type: news